Kidswell Bio Corporation (4584.T)
JPY 132.0
(0.76%)
JPY 132.0
(0.76%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.37 Billion JPY | 14.37% |
| 2022 | 2.07 Billion JPY | 24.35% |
| 2021 | 1.67 Billion JPY | -9.57% |
| 2020 | 1.84 Billion JPY | -76.12% |
| 2019 | 7.73 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 382.56 Million JPY | -54.73% |
| 2023 Q2 | 449.45 Million JPY | -10.14% |
| 2023 Q1 | 500.17 Million JPY | -42.39% |
| 2023 Q4 | 845.02 Million JPY | 45.61% |
| 2023 Q3 | 580.33 Million JPY | 29.12% |
| 2023 FY | 2.37 Billion JPY | 14.37% |
| 2022 Q3 | -152.24 Million JPY | -146.44% |
| 2022 FY | 2.07 Billion JPY | 24.35% |
| 2022 Q4 | 868.27 Million JPY | 670.33% |
| 2022 Q2 | 327.85 Million JPY | 0.0% |
| 2021 FY | 1.67 Billion JPY | -9.57% |
| 2020 FY | 1.84 Billion JPY | -76.12% |
| 2019 FY | 7.73 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.28 Billion JPY | -84.828% |
| PRISM BioLab Co.,LTD | 576.81 Million JPY | -311.581% |
| GNI Group Ltd. | 9.32 Billion JPY | 74.534% |
| Linical Co., Ltd. | 2.7 Billion JPY | 12.24% |
| Trans Genic Inc. | 2.15 Billion JPY | -9.919% |
| MEDINET Co., Ltd. | 1.49 Billion JPY | -59.209% |
| Soiken Holdings Inc. | 3.07 Billion JPY | 22.696% |
| Cytori Cell Research Institute, Inc. | 1.85 Billion JPY | -27.846% |
| AnGes, Inc. | 8.9 Billion JPY | 73.332% |
| OncoTherapy Science, Inc. | 943.08 Million JPY | -151.735% |
| Nxera Pharma Co., Ltd. | 19.19 Billion JPY | 87.629% |
| Immuno-Biological Laboratories Co., Ltd. | 412.99 Million JPY | -474.848% |
| NanoCarrier Co., Ltd. | 975.37 Million JPY | -143.401% |
| Carna Biosciences, Inc. | 2.56 Billion JPY | 7.537% |
| CanBas Co., Ltd. | 278 Million JPY | -753.979% |
| D. Western Therapeutics Institute, Inc. | 1.14 Billion JPY | -107.971% |
| RaQualia Pharma Inc. | 1.81 Billion JPY | -30.59% |
| Chiome Bioscience Inc. | 1.6 Billion JPY | -48.031% |
| PeptiDream Inc. | 9.68 Billion JPY | 75.493% |
| Oncolys BioPharma Inc. | 1.96 Billion JPY | -21.089% |
| Ribomic Inc. | 1.1 Billion JPY | -114.713% |
| SanBio Company Limited | 4.53 Billion JPY | 47.696% |
| Healios K.K. | 3.48 Billion JPY | 31.917% |
| BrightPath Biotherapeutics Co., Ltd. | 1.15 Billion JPY | -105.593% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 1.33 Billion JPY | -77.904% |
| Delta-Fly Pharma, Inc. | 1.4 Billion JPY | -69.158% |
| StemRIM | 2.07 Billion JPY | -14.358% |
| CellSource Co., Ltd. | 1.96 Billion JPY | -20.91% |
| FunPep Company Limited | 313.82 Million JPY | -656.502% |
| Kringle Pharma, Inc. | 958.01 Million JPY | -147.811% |
| Stella Pharma Corporation | 963.98 Million JPY | -146.276% |
| TMS Co., Ltd. | 943.25 Million JPY | -151.689% |
| Noile-Immune Biotech Inc. | 1.08 Billion JPY | -117.814% |
| Cuorips Inc. | 598.11 Million JPY | -296.922% |
| K Pharma,Inc. | 543.94 Million JPY | -336.455% |
| Takara Bio Inc. | 23.9 Billion JPY | 90.069% |
| ReproCELL Incorporated | 1.51 Billion JPY | -56.806% |
| PhoenixBio Co., Ltd. | 1.18 Billion JPY | -100.514% |
| StemCell Institute Inc. | 1.16 Billion JPY | -104.287% |
| Japan Tissue Engineering Co., Ltd. | 1.52 Billion JPY | -55.955% |
| CellSeed Inc. | 804.93 Million JPY | -194.94% |